Similarly, in MRL/lpr mice, another spontaneous lupus murine model, Btk inhibition was able to normalize proteinuria with early treatment, and reverse established proteinuria when administrated at the late phase of the disease (25). Here, BTK is linked to systemic lupus erythematosus.